12 Health Care Stocks Moving In Thursday's Pre-Market Session

Loading...
Loading...

Gainers

  • Tenax Therapeutics TENX shares rose 153.2% to $4.28 during Thursday's pre-market session. The company's market cap stands at $9.8 million.
  • Biophytis BPTS stock rose 119.45% to $0.9. The company's market cap stands at $18.3 million. The company's, H1 earnings came out 2 days ago.
  • Lannett LCI stock rose 37.22% to $0.74. The market value of their outstanding shares is at $31.0 million. The company's, Q2 earnings came out yesterday.
  • Rockwell Medical RMTI shares rose 30.81% to $2.08. The company's market cap stands at $24.1 million.
  • Science 37 Hldgs SNCE stock moved upwards by 24.9% to $0.67. The company's market cap stands at $78.1 million.
  • Align Tech ALGN stock moved upwards by 15.52% to $326.39. The company's market cap stands at $25.4 billion. As per the press release, Q4 earnings came out yesterday.

Losers

  • OncoSec Medical ONCS stock declined by 28.2% to $1.53 during Thursday's pre-market session. The company's market cap stands at $4.5 million.
  • TransCode Therapeutics RNAZ stock declined by 24.87% to $0.65. The company's market cap stands at $8.4 million.
  • AnPac Bio-Medical Science ANPC stock declined by 14.39% to $7.5. The company's market cap stands at $15.2 million.
  • Vera Therapeutics VERA stock declined by 13.31% to $7.36. The market value of their outstanding shares is at $203.5 million.
  • Adial Pharmaceuticals ADIL shares fell 12.94% to $0.4. The market value of their outstanding shares is at $10.7 million.
  • Ambrx Biopharma AMAM shares decreased by 8.52% to $1.72. The market value of their outstanding shares is at $66.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: MoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...